SISAQOL-IMI: Setting standards for the use of patient-reported outcome data in cancer trials
1 Jun 2023
EORTC QLG proudly collaborates on the EUonQoL project
21 Mar 2023
EORTC: Working towards “Closing the Care Gap”
2 Feb 2023
First EORTC anal cancer-specific questionnaire validated
18 Nov 2022
EORTC Quality of Life Group celebrating 40 years
22 Sep 2022
EORTC Item Library provides considerable coverage of CTCAE side effects, new study finds
31 Aug 2022
PRESS RELEASE: Better treatment for better health: lifting the veil on treatment optimisation
27 Jun 2022
MSD’s KEYTRUDA® (pembrolizumab) Significantly Improved Disease-Free Survival (DFS) Versus Placebo as Adjuvant Therapy in Patients With Stage IB-IIIA Non-Small Cell Lung Cancer (NSCLC) Regardless of PD-L1 Expression
17 Mar 2022